Literature DB >> 31420742

Risk factors for the recurrence of perineal canal.

Keisuke Kajihara1, Hiroaki Fukuzawa2, Koji Fukumoto3, Naoto Urushihara3, Yoshitomo Samejima2, Kotaro Uemura2, Kozo Nomura2, Insu Kawahara2, Kaori Isono2, Keiiti Morita2, Makoto Nakao2, Akiko Yokoi2, Kosaku Maeda2.   

Abstract

PURPOSE: The aim of this study was to investigate risk factors for recurrence in the perineal canal (PC).
METHODS: Patients with PC who underwent operations were enrolled in this study and were divided into recurrence and non-recurrence groups. Preoperative infection, the age at the operation, the presence of colostomy and the treatment procedure for fistula were retrospectively investigated. Regarding the treatment procedure for fistula, either closure of the rectal wall with stitches or ligation of fistula in the rectum was performed. These factors were compared between the two groups.
RESULTS: Six of 17 patients with PC who underwent surgical treatment had recurrence. There were no significant differences in the incidence of preoperative infection, age at operation or presence of colostomy (p = 0.60, 0.38, 1.00, respectively). In the recurrence group, all patients were treated by closure of the rectal wall. In the non-recurrence group, five were treated by the closure of the rectal wall with stitches and six by ligation of the fistula. There was a significant association between recurrence and the treatment procedure for fistula (p = 0.04).
CONCLUSION: Closure of the rectal wall with stitches is a risk factor for the recurrence of PC.

Entities:  

Keywords:  Ligation of fistula; Perineal canal; Risk factor for recurrence; Vestibulo-anal pull-through

Mesh:

Year:  2019        PMID: 31420742     DOI: 10.1007/s00383-019-04536-8

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  10 in total

1.  Surgical repair of rectovestibular fistula with normal anus.

Authors:  C Tsugawa; E Nishijima; T Muraji; S Satoh; K Kimura
Journal:  J Pediatr Surg       Date:  1999-11       Impact factor: 2.545

2.  Congenital H-type anovestibuler fistula.

Authors:  Mesut Yazlcl; Barlas Etensel; Harun Gürsoy; Sezen Ozklsaclk
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

3.  Double termination of the alimentary tract in female infants.

Authors:  S K Chatterjee; B C Talukder
Journal:  J Pediatr Surg       Date:  1969-04       Impact factor: 2.545

Review 4.  The surgical management of H-type rectovestibular fistula: a case report and brief review of the literature.

Authors:  Deirdre C Kelleher; Peter W Henderson; Arnold Coran; Nitsana A Spigland
Journal:  Pediatr Surg Int       Date:  2012-02-15       Impact factor: 1.827

5.  Management of H-type rectovestibular and rectovaginal fistulas.

Authors:  Taiwo A Lawal; Kaveer Chatoorgoon; Andrea Bischoff; Alberto Peña; Marc A Levitt
Journal:  J Pediatr Surg       Date:  2011-06       Impact factor: 2.545

6.  Management of male H-type anorectal malformations.

Authors:  Tahmina Banu; Mozammel Hoque; Kamrun Laila; Abdul Hanif
Journal:  Pediatr Surg Int       Date:  2009-10       Impact factor: 1.827

7.  The Surgical Management of H-Type Rectovestibular Fistula: A Novel Modification.

Authors:  Ye-Ming Wu; Cheng-Dong Wang; Fan Lv; Chi Zhang; Zhi-Long Yan
Journal:  Eur J Pediatr Surg       Date:  2015-05-29       Impact factor: 2.191

8.  H-type anorectal malformations: incidence and clinical characteristics.

Authors:  R J Rintala; L Mildh; H Lindahl
Journal:  J Pediatr Surg       Date:  1996-04       Impact factor: 2.545

Review 9.  Diversities of H-type anorectal malformation: a systematic review on a rare variant of the Krickenbeck classification.

Authors:  Shilpa Sharma; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2016-10-01       Impact factor: 1.827

10.  Double termination of the alimentary tract in females: a report of 12 cases and a literature review.

Authors:  Y Tsuchida; S Saito; T Honna; S Makino; M Kaneko; H Hazama
Journal:  J Pediatr Surg       Date:  1984-06       Impact factor: 2.545

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.